IC 35-45-6-1 : Definitions
Sec. 1. (a) The definitions in this section apply throughout this chapter.
(b) "Documentary material" means any document, drawing, photograph, recording, or other tangible item containing compiled data from which information can be either obtained or translated into a usable form.
(c) "Enterprise" means:
(1) a sole proprietorship, corporation, limited liability company, partnership, business trust, or governmental entity; or
(2) a union, an association, or a group, whether a legal entity or merely associated in fact.
(d) "Pattern of racketeering activity" means engaging in at least two (2) incidents of racketeering activity that have the same or similar intent, result, accomplice, victim, or method of commission, or that are otherwise interrelated by distinguishing characteristics that are not isolated incidents. However, the incidents are a pattern of racketeering activity only if at least one (1) of the incidents occurred after August 31, 1980, and if the last of the incidents occurred within five (5) years after a prior incident of racketeering activity.
(e) "Racketeering activity" means to commit, to attempt to commit, to conspire to commit a violation of, or aiding and abetting in a violation of any of the following:
(6) Battery as a Class C felony before July 1, 2014, or a Level 5 felony after June 30, 2014 (IC 35-42-2-1). (15) Receiving stolen property (IC 35-43-4-2) (before its amendment on July 1, 2018). (28) Dealing in or manufacturing cocaine or a narcotic drug (IC 35-48-4-1). (31) Dealing in a schedule I, II, or III controlled substance (IC 35-48-4-2). (32) Dealing in a schedule IV controlled substance (IC 35-48-4-3). (33) Dealing in a schedule V controlled substance (IC 35-48-4-4). (34) Dealing in marijuana, hash oil, hashish, or salvia (IC 35-48-4-10). (37) A violation of any of the following:
(38) Practice of law by a person who is not an attorney (IC 33-43-2-1). (39) An offense listed in IC 35-48-4 involving the manufacture or sale of a synthetic drug (as defined in IC 35-31.5-2-321), a synthetic drug lookalike substance (as defined in IC 35-31.5-2-321.5 (before its repeal on July 1, 2019)) under IC 35-48-4-10.5 (before its repeal on July 1, 2019), a controlled substance analog (as defined in IC 35-48-1-9.3), or a substance represented to be a controlled substance (as described in IC 35-48-4-4.6). (40) Dealing in a controlled substance resulting in death (IC 35-42-1-1.5). As added by Acts 1980, P.L.199, SEC.2. Amended by P.L.190-1984, SEC.1; P.L.180-1991, SEC.10; P.L.230-1993, SEC.4; P.L.8-1993, SEC.511; P.L.112-1998, SEC.1; P.L.17-2001, SEC.16; P.L.123-2002, SEC.41; P.L.151-2006, SEC.17; P.L.173-2006, SEC.53; P.L.1-2007, SEC.234; P.L.227-2007, SEC.68; P.L.27-2007, SEC.31; P.L.3-2008, SEC.253; P.L.143-2009, SEC.48; P.L.138-2011, SEC.11; P.L.182-2011, SEC.11; P.L.126-2012, SEC.56; P.L.149-2012, SEC.19; P.L.13-2013, SEC.143; P.L.196-2013, SEC.18; P.L.158-2013, SEC.534; P.L.168-2014, SEC.84; P.L.252-2017, SEC.16; P.L.198-2018, SEC.8; P.L.176-2018, SEC.8; P.L.80-2019, SEC.17; P.L.25-2022, SEC.1.